Roche's Boniva Patent Declared Invalid
A New Jersey federal judge on Monday invalidated the remaining patent in Hoffmann-La Roche Inc.'s consolidated lawsuits against Apotex Inc., Mylan Inc. and other generic drugmakers over the osteoporosis drug Boniva,...To view the full article, register now.
Already a subscriber? Click here to view full article